United States Biotechnology & Medical Research

Mink Therapeutics Inc (INKT)

Track

Mink Therapeutics experienced recent insider trading activity characterized by net selling. Barbara Ryan executed two sales totaling approximately $19,141 over the past ninety days. These divestments occur while the stock trades near its fifty-two-week low, following a significant miss in the latest earnings report.
Ticker: INKT Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Mink Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.2
Ryan Barbara Non-Executive Director
Transaction date
Sale
Price
479.87
Quantity 56,082 -9.2%
Value US$2,956,021
3.2
Ryan Barbara Non-Executive Director
Transaction date
Sale
Price
42.02
Quantity 51,171 -29.1%
Value US$3,239,673
3.2
Ryan Barbara Non-Executive Director
Transaction date
Sale
Price
207.32
Quantity 35,476 +17.6%
Value US$4,930,225
3.2
Ryan Barbara Non-Executive Director
Transaction date
Sale
Price
15.57
Quantity 500 -2.3%
Value US$7,783
3.2
Ryan Barbara Non-Executive Director
Transaction date
Sale
Price
15.28
Quantity 300 -1.4%
Value US$4,585
3.2
Ryan Barbara Non-Executive Director
Transaction date
Sale
Price
10.17
Quantity 200 -0.9%
Value US$2,034
3.2
Ryan Barbara Non-Executive Director
Transaction date
Sale
Price
10.83
Quantity 100 -0.5%
Value US$1,083
3.2
Ryan Barbara Non-Executive Director
Transaction date
Sale
Price
10.86
Quantity 400 -1.8%
Value US$4,343
2.5
Agenus Inc. Owner
Transaction date
Proposed sale
Price
15.98
Quantity 786,750
Value US$12,572,265
2.5
AGENUS INC Large shareholder
Transaction date
Purchase
Price
1.10
Quantity 429 +0.0%
Value US$472
2.5
AGENUS INC Large shareholder
Transaction date
Purchase
Price
1.10
Quantity 19,373 +0.1%
Value US$21,310
2.5
AGENUS INC Large shareholder
Transaction date
Purchase
Price
1.10
Quantity 3,173 +0.0%
Value US$3,488
2.5
AGENUS INC Large shareholder
Transaction date
Purchase
Price
1.09
Quantity 15,001 +0.1%
Value US$16,380
2.5
AGENUS INC Large shareholder
Transaction date
Purchase
Price
1.52
Quantity 29,678 +0.1%
Value US$45,016
2.5
AGENUS INC Large shareholder
Transaction date
Purchase
Price
1.45
Quantity 12,808 +0.1%
Value US$18,570
2.5
AGENUS INC Large shareholder
Transaction date
Purchase
Price
1.54
Quantity 170,244 +0.8%
Value US$262,908
2.5
AGENUS INC Large shareholder
Transaction date
Purchase
Price
1.43
Quantity 23,361 +0.1%
Value US$33,348
2.5
AGENUS INC Large shareholder
Transaction date
Purchase
Price
1.51
Quantity 22,065 +0.1%
Value US$33,296
2.5
AGENUS INC Large shareholder
Transaction date
Purchase
Price
1.25
Quantity 200 +0.0%
Value US$250
2.5
AGENUS INC Large shareholder
Transaction date
Purchase
Price
0.95
Quantity 100,000 +0.5%
Value US$94,850
2.4
ARMEN GARO H Non-Executive Director
Transaction date
Sale
Price
0.95
Quantity 100,000 -5.1%
Value US$94,850
2.5
AGENUS INC Large shareholder
Transaction date
Purchase
Price
1.22
Quantity 21,473 +0.1%
Value US$26,246
2.5
AGENUS INC Large shareholder
Transaction date
Purchase
Price
1.08
Quantity 128,689 +0.6%
Value US$138,843
2.4
ARMEN GARO H Non-Executive Director
Transaction date
Purchase
Price
0.95
Quantity 100,000 +5.3%
Value US$94,850
3.4
WIINBERG ULF Non-Executive Director
Transaction date
Purchase
Price
1.39
Quantity 16,661 +5.9%
Value US$23,209
3.4
WIINBERG ULF Non-Executive Director
Transaction date
Purchase
Price
1.33
Quantity 3,339 +1.2%
Value US$4,438
2.5
AGENUS INC Large shareholder
Transaction date
Purchase
Price
12.00
Quantity 1,400,000 +7.2%
Value US$16,800,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-05 2026-06-04 S Sale
3.2
Ryan Barbara
Non-Executive Director
56,082 -9.2%
479.87
US$2,956,021 		56,082 -9.2% 479.87 US$2,956,021
2026-06-05 2026-06-04 S Sale
3.2
Ryan Barbara
Non-Executive Director
51,171 -29.1%
42.02
US$3,239,673 		51,171 -29.1% 42.02 US$3,239,673
2026-03-11 2026-03-10 S Sale
3.2
Ryan Barbara
Non-Executive Director
35,476 +17.6%
207.32
US$4,930,225 		35,476 +17.6% 207.32 US$4,930,225
2026-03-11 2026-03-10 S Sale
3.2
Ryan Barbara
Non-Executive Director
500 -2.3%
15.57
US$7,783 		500 -2.3% 15.57 US$7,783
2026-03-11 2026-03-10 S Sale
3.2
Ryan Barbara
Non-Executive Director
300 -1.4%
15.28
US$4,585 		300 -1.4% 15.28 US$4,585
2026-03-11 2026-03-09 S Sale
3.2
Ryan Barbara
Non-Executive Director
200 -0.9%
10.17
US$2,034 		200 -0.9% 10.17 US$2,034
2026-03-04 2026-03-02 S Sale
3.2
Ryan Barbara
Non-Executive Director
100 -0.5%
10.83
US$1,083 		100 -0.5% 10.83 US$1,083
2026-03-04 2026-02-27 S Sale
3.2
Ryan Barbara
Non-Executive Director
400 -1.8%
10.86
US$4,343 		400 -1.8% 10.86 US$4,343
2025-08-29 2025-08-29 PrS Proposed sale
2.5
Agenus Inc.

Owner
786,750
15.98
US$12,572,265 		786,750 15.98 US$12,572,265
2023-10-16 2023-10-16 B Purchase
2.5
AGENUS INC
Large shareholder
429 +0.0%
1.10
US$472 		429 +0.0% 1.10 US$472
2023-10-16 2023-10-13 B Purchase
2.5
AGENUS INC
Large shareholder
19,373 +0.1%
1.10
US$21,310 		19,373 +0.1% 1.10 US$21,310
2023-10-16 2023-10-12 B Purchase
2.5
AGENUS INC
Large shareholder
3,173 +0.0%
1.10
US$3,488 		3,173 +0.0% 1.10 US$3,488
2023-10-06 2023-10-04 B Purchase
2.5
AGENUS INC
Large shareholder
15,001 +0.1%
1.09
US$16,380 		15,001 +0.1% 1.09 US$16,380
2023-08-31 2023-08-29 B Purchase
2.5
AGENUS INC
Large shareholder
29,678 +0.1%
1.52
US$45,016 		29,678 +0.1% 1.52 US$45,016
2023-08-28 2023-08-28 B Purchase
2.5
AGENUS INC
Large shareholder
12,808 +0.1%
1.45
US$18,570 		12,808 +0.1% 1.45 US$18,570
2023-08-28 2023-08-24 B Purchase
2.5
AGENUS INC
Large shareholder
170,244 +0.8%
1.54
US$262,908 		170,244 +0.8% 1.54 US$262,908
2023-05-12 2023-05-11 B Purchase
2.5
AGENUS INC
Large shareholder
23,361 +0.1%
1.43
US$33,348 		23,361 +0.1% 1.43 US$33,348
2023-05-12 2023-05-10 B Purchase
2.5
AGENUS INC
Large shareholder
22,065 +0.1%
1.51
US$33,296 		22,065 +0.1% 1.51 US$33,296
2023-05-05 2023-05-05 B Purchase
2.5
AGENUS INC
Large shareholder
200 +0.0%
1.25
US$250 		200 +0.0% 1.25 US$250
2023-05-05 2023-05-05 B Purchase
2.5
AGENUS INC
Large shareholder
100,000 +0.5%
0.95
US$94,850 		100,000 +0.5% 0.95 US$94,850
2023-05-05 2023-05-05 S Sale
2.4
ARMEN GARO H
Non-Executive Director
100,000 -5.1%
0.95
US$94,850 		100,000 -5.1% 0.95 US$94,850
2023-05-05 2023-05-04 B Purchase
2.5
AGENUS INC
Large shareholder
21,473 +0.1%
1.22
US$26,246 		21,473 +0.1% 1.22 US$26,246
2023-05-05 2023-05-03 B Purchase
2.5
AGENUS INC
Large shareholder
128,689 +0.6%
1.08
US$138,843 		128,689 +0.6% 1.08 US$138,843
2023-05-04 2023-05-02 B Purchase
2.4
ARMEN GARO H
Non-Executive Director
100,000 +5.3%
0.95
US$94,850 		100,000 +5.3% 0.95 US$94,850
2022-07-21 2022-07-19 B Purchase
3.4
WIINBERG ULF
Non-Executive Director
16,661 +5.9%
1.39
US$23,209 		16,661 +5.9% 1.39 US$23,209
2022-07-21 2022-07-18 B Purchase
3.4
WIINBERG ULF
Non-Executive Director
3,339 +1.2%
1.33
US$4,438 		3,339 +1.2% 1.33 US$4,438
2021-10-20 2021-10-19 B Purchase
2.5
AGENUS INC
Large shareholder
1,400,000 +7.2%
12.00
US$16,800,000 		1,400,000 +7.2% 12.00 US$16,800,000
Explore more

More insider trading research around Mink Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America